BECN1 gene expression were enhanced in leukocytes from T2D patients with respect to those of healthy controls (Figure 3A; p < 0.05), a trend that was reversed by treatment with SS-31 (Figure 3A; p < 0.05). The gene discussed is BECN1; the disease is type 2 diabetes mellitus.